VAS 约8条结果 (0.63秒)

期刊论文
Treatment of skin soft tissue embolism after hyaluronic acid injection for injection rhinoplasty in Asian patients
Ouyang, Hua-Wei; Li, Gao-Feng; Zhu, Yi; Lei, Ying; Gold, Michael H.; Tan, Jun Department of Plastic & Laser Cosmetic, Hunan Provincial People's Hospital, Changsha, China; Gold Skin Care Center, Nashville, Tennessee Journal of Cosmetic Dermatology 2019

摘要:Introduction The purpose of this manuscript is to investigate the treatment of skin soft tissue embolization or vascular occlusion after the injection of hyaluronic acid (HA) for Injection Rhinoplasty (IR) in Asians with a special interest in the time occurrence of the occlusion. Methods A total of 35 cases were evaluated after receiving HA injections for IR who presented with a vascular occlusive event. They were divided into three stages based on the time to embolization. Immediate, ≤5 hours; early, ≤3 days; and late, >3 days. There were two cases of immediate, 28 deemed early, and five late. Methods to prevent tissue necrosis are reviewed in the manuscript based on these stages. Results Skin color gradually recovered to normal after 11 treatments in 11 patients with mild embolization. No ischemic aggravation or skin necrosis was observed in 19 patients with moderate embolization; red scarring was seen in two and hypertrophic scar with uneven skin color in one patient. The five patients in the severe category had longer healing, more red scars, and more hypertrophic scarring. Conclusion The treatment of skin soft tissue embolization or vascular occlusion after HA IR in Asians can be effected by identifying the stage and degree of embolization and treating appropriately with the outlines presented in this manuscript.

期刊论文
Successful Combined Treatment with Total Parenteral Nutrition Fluid Extravasation Injuries in Preterm Infants
Cho, Ky Young; Lee, Soo Jung; Burm, Jin Sik; Park, Eun Ae Depariments of Pedatrics, Plastic Surgery, Ewha Womans University College of Medicine, Seoul, Korea Journal of Korean Medical Science 2007

摘要:Extravasation injuries in the neonatal intensive care unit are not rare during parenteral hyperalimentation. There have been many different methods of management. We report five premature infants with wounds of hyperalimentation fluid extravasation managed by the antibacterial ointment (Terramycin ophthalmic ointment?) and sesame oil and a antiinflammatory herbal mixture (MEBO?). The mean gestational age of patients was 31+2 weeks (range, 28+4 to 35+6 weeks), and the mean weight at extravasation was 1,930 g (range, 1,140 to 2,680 g). Extravasation occurred within the mean of 32 days (range, 17 to 50 days). The method of dressing was application of a thick layer of this mixture covered by vaseline and wet gauze renewed at an interval of 8-12 hr after irrigating the wounds thoroughly with normal saline. The mean duration of dressing was 30 days (range, 20-50 days). The wounds had healed completely leaving a small size of contracture without functional abnormality. We conclude that this therapy may be considered for an alternative treatment and warrants clinical trials for the confirmation of the local management of extravasation injury.

期刊论文
Expression and predictive value of HIF-1α and VEGF in patients with burns following treatment
Liu, Zhufeng; Liu, Ling; Cheng, Xuejuan; Gao, Liming Department of Burn Dermatology, Jinan City People's Hospital, Jinan, Shandong 271100; Department of Nursing, The People's Hospital of Zouping City, Binzhou, Shandong 256200, P.R. China Experimental and Therapeutic Medicine 2020

摘要:The present study aimed to investigate the expression and predictive value of serum hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in patients with burns following treatment. A total of 84 patients with burns treated in Jinan City People's Hospital (Jinan, China) between June 2015 and August 2017 were selected and their clinical information was collected. The expression levels of HIF-1α and VEGF before and after treatment were detected via ELISA, and HIF-1α and VEGF levels in patients with effective and ineffective treatment were compared. The predictive values of HIF-1α and VEGF in clinical efficacy were determined using receiver operating characteristic (ROC) curves, and independent risk factors affecting treatment inefficacy were analyzed via multivariate logistic regression. It was revealed that HIF-1α decreased significantly (P<0.05) while VEGF significantly increased in patients after treatment. Patients with effective treatment presented significantly lower HIF-1α levels and higher VEGF levels compared with those with ineffective treatment. The ROC curve indicated that the area under the curve (AUC) of HIF-1α for treatment efficacy was 0.795, the 95% CI was 0.666-0.924, the specificity and sensitivity were 68.75 and 80.88%, respectively, and the Youden index was 49.63%. For VEGF, the AUC, 95% CI, specificity, sensitivity and Youden index were 0.826, 0.725-0.928, 68.75, 82.35 and 51.10% respectively. Moreover, under the joint detection of HIF-1α and VEGF, the AUC was 0.847, 95% CI was 0.746-0.947, specificity and sensitivity were 87.50 and 66.18%, respectively, with a Youden index of 53.68%. Multivariate analysis demonstrated that higher HIF-1α level, lower VEGF level and higher burn degree before treatment were independent risk factors for treatment inefficacy. HIF-1α levels decreased and VEGF levels increased in burn patients after treatment. HIF-1α and VEGF before treatment may therefore serve as predictors for treatment efficacy.

期刊论文
Clinical Study Report on Treating Split Skin Thickness Donor Site in Skin Regeneration in Situ with MEBO
group, Special subject study 中国烧伤创疡杂志 2006

摘要:<正>To extend clinical application of skin regeneration in .situ technique with MEBO on split skin thickness donor site a protocol was made for clinical study of treating skin donor site in skin regeneration is situ technique with MEBO in Octobcr of 2005 .The protocol was sent to hospitals that had carried out such study for their conducting the study .The data

再生医学汇
AI Research Assistant

您好,我是再生医学汇AI助手

您的专业再生医学研究助理,准备好探索生命科学了